$515 Million is the total value of Integral Health Asset Management, LLC's 65 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 67.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GH | Buy | GUARDANT HEALTH INC | $24,224,000 | +55.9% | 450,000 | +16.8% | 4.71% | +47.2% |
| New | CYTOKINETICS INCcall | $22,108,000 | – | 456,300 | +100.0% | 4.30% | – | |
| ANTM | Sell | ELEVANCE HEALTH INC | $18,170,000 | -44.5% | 40,000 | -41.0% | 3.53% | -47.6% |
| CNC | Sell | CENTENE CORP DEL | $17,507,000 | -40.9% | 225,000 | -35.7% | 3.40% | -44.2% |
| CYTK | Sell | CYTOKINETICS INC | $16,958,000 | -17.8% | 350,000 | -33.3% | 3.29% | -22.4% |
| BAX | New | BAXTER INTL INC | $16,158,000 | – | 300,000 | +100.0% | 3.14% | – |
| MRK | Buy | MERCK & CO INC | $15,932,000 | +67.4% | 185,000 | +77.3% | 3.10% | +58.2% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $14,436,000 | -3.0% | 440,000 | +13.9% | 2.80% | -8.4% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $14,377,000 | +195.7% | 220,000 | +175.0% | 2.79% | +179.3% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $14,011,000 | +104.5% | 70,000 | +49.0% | 2.72% | +93.2% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $13,980,000 | +5.0% | 357,000 | -13.4% | 2.72% | -0.8% |
| BSX | New | BOSTON SCIENTIFIC CORP | $13,556,000 | – | 350,000 | +100.0% | 2.63% | – |
| RLAY | Buy | RELAY THERAPEUTICS INC | $13,422,000 | +83.7% | 600,000 | +37.5% | 2.61% | +73.5% |
| BIIB | New | BIOGEN INC | $13,350,000 | – | 50,000 | +100.0% | 2.59% | – |
| CAH | New | CARDINAL HEALTH INC | $13,336,000 | – | 200,000 | +100.0% | 2.59% | – |
| CVS | Sell | CVS HEALTH CORP | $12,398,000 | -5.0% | 130,000 | -7.7% | 2.41% | -10.3% |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $11,913,000 | +24.6% | 550,000 | +61.6% | 2.31% | +17.6% |
| PRGO | Buy | PERRIGO CO PLC | $11,411,000 | +54.0% | 320,000 | +75.2% | 2.22% | +45.5% |
| MCK | Sell | MCKESSON CORP | $10,196,000 | -25.1% | 30,000 | -28.1% | 1.98% | -29.3% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $9,559,000 | – | 90,000 | +100.0% | 1.86% | – |
| SNY | Sell | SANOFIsponsored adr | $9,505,000 | -45.7% | 250,000 | -28.6% | 1.85% | -48.8% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $9,070,000 | -13.3% | 107,000 | -15.3% | 1.76% | -18.2% |
| PTCT | Buy | PTC THERAPEUTICS INC | $8,183,000 | +95.2% | 163,000 | +55.7% | 1.59% | +84.5% |
| QURE | Buy | UNIQURE NV | $8,123,000 | +23.4% | 433,000 | +22.6% | 1.58% | +16.5% |
| LLY | Sell | LILLY ELI & CO | $8,084,000 | -65.9% | 25,000 | -65.8% | 1.57% | -67.8% |
| AKRO | Sell | AKERO THERAPEUTICS INC | $7,832,000 | +187.7% | 230,000 | -20.2% | 1.52% | +171.6% |
| DHR | New | DANAHER CORPORATION | $7,749,000 | – | 30,000 | +100.0% | 1.50% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $7,576,000 | – | 15,000 | +100.0% | 1.47% | – |
| INSP | New | INSPIRE MED SYS INC | $7,095,000 | – | 40,000 | +100.0% | 1.38% | – |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $6,995,000 | +61.8% | 125,000 | +49.7% | 1.36% | +52.9% |
| KURA | Buy | KURA ONCOLOGY INC | $6,830,000 | -19.2% | 500,000 | +8.4% | 1.33% | -23.7% |
| ISEE | New | IVERIC BIO INC | $6,728,000 | – | 375,000 | +100.0% | 1.31% | – |
| THC | Sell | TENET HEALTHCARE CORP | $6,705,000 | -49.1% | 130,000 | -48.1% | 1.30% | -51.9% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $6,273,000 | +83.1% | 90,000 | +72.5% | 1.22% | +72.9% |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $6,264,000 | +1.0% | 50,000 | -12.9% | 1.22% | -4.6% |
| DVA | Buy | DAVITA INC | $6,208,000 | +48.8% | 75,000 | +43.7% | 1.21% | +40.6% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $6,128,000 | -6.7% | 93,000 | -28.5% | 1.19% | -11.9% |
| PODD | New | INSULET CORP | $5,735,000 | – | 25,000 | +100.0% | 1.11% | – |
| ILMN | New | ILLUMINA INC | $5,724,000 | – | 30,000 | +100.0% | 1.11% | – |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $5,352,000 | +34.1% | 340,000 | +18.9% | 1.04% | +26.7% |
| MRTX | New | MIRATI THERAPEUTICS INC | $4,889,000 | – | 70,000 | +100.0% | 0.95% | – |
| EXAS | New | EXACT SCIENCES CORP | $4,874,000 | – | 150,000 | +100.0% | 0.95% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $4,781,000 | +6.6% | 70,000 | -29.4% | 0.93% | +0.8% |
| NVRO | Buy | NEVRO CORP | $4,660,000 | +35.8% | 100,000 | +27.8% | 0.90% | +28.2% |
| ALKS | Sell | ALKERMES PLC | $4,466,000 | -42.8% | 200,000 | -23.7% | 0.87% | -45.9% |
| RVNC | New | REVANCE THERAPEUTICS INC | $4,050,000 | – | 150,000 | +100.0% | 0.79% | – |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $3,715,000 | +15.2% | 195,000 | +24.6% | 0.72% | +8.9% |
| GOSS | New | GOSSAMER BIO INC | $3,594,000 | – | 300,000 | +100.0% | 0.70% | – |
| DNLI | New | DENALI THERAPEUTICS INC | $3,529,000 | – | 115,000 | +100.0% | 0.69% | – |
| New | VENTYX BIOSCIENCES INC | $3,491,000 | – | 100,000 | +100.0% | 0.68% | – | |
| SIBN | Buy | SI-BONE INC | $3,492,000 | +68.1% | 200,000 | +27.1% | 0.68% | +58.8% |
| LFST | Buy | LIFESTANCE HEALTH GROUP INC | $3,476,000 | +66.4% | 525,000 | +39.7% | 0.68% | +57.0% |
| REPL | Sell | REPLIMUNE GROUP INC | $3,454,000 | -9.9% | 200,000 | -8.8% | 0.67% | -14.8% |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $3,306,000 | +269.0% | 92,000 | -29.3% | 0.64% | +248.9% |
| AMED | New | AMEDISYS INC | $3,194,000 | – | 33,000 | +100.0% | 0.62% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $2,954,000 | +5.9% | 700,000 | -30.0% | 0.57% | 0.0% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $2,828,000 | – | 100,000 | +100.0% | 0.55% | – |
| DSGN | New | DESIGN THERAPEUTICS INC | $2,090,000 | – | 125,000 | +100.0% | 0.41% | – |
| ARCT | Sell | ARCTURUS THERAPEUTICS HLDGS | $1,927,000 | -21.8% | 130,000 | -17.0% | 0.37% | -26.2% |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $1,857,000 | – | 30,000 | +100.0% | 0.36% | – |
| Buy | CINCOR PHARMA INC | $1,641,000 | +108.5% | 50,000 | +19.8% | 0.32% | +96.9% | |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $1,357,000 | -82.1% | 130,000 | -81.5% | 0.26% | -83.0% |
| MIRM | Sell | MIRUM PHARMACEUTICALS INC | $1,051,000 | -69.6% | 50,000 | -71.8% | 0.20% | -71.3% |
| MGTA | Buy | MAGENTA THERAPEUTICS INC | $532,000 | +35.0% | 377,000 | +14.8% | 0.10% | +27.2% |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $409,000 | +131.1% | 110,000 | +91.9% | 0.08% | +119.4% |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.12% | – |
| ATRA | Exit | ATARA BIOTHERAPEUTICS INC | $0 | – | -208,738 | -100.0% | -0.33% | – |
| INSM | Exit | INSMED INC | $0 | – | -104,369 | -100.0% | -0.42% | – |
| KNSA | Exit | KINIKSA PHARMACEUTICALS LTD | $0 | – | -234,830 | -100.0% | -0.47% | – |
| NSTG | Exit | NANOSTRING TECHNOLOGIES INC | $0 | – | -188,500 | -100.0% | -0.49% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -97,281 | -100.0% | -0.61% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -104,369 | -100.0% | -0.65% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLC | $0 | – | -20,874 | -100.0% | -0.67% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -124,369 | -100.0% | -0.85% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -41,748 | -100.0% | -0.90% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -78,277 | -100.0% | -0.92% | – |
| AGL | Exit | AGILON HEALTH INC | $0 | – | -230,655 | -100.0% | -1.04% | – |
| ZLAB | Exit | ZAI LAB LTDadr | $0 | – | -156,554 | -100.0% | -1.12% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -31,311 | -100.0% | -1.14% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -40,000 | -100.0% | -1.18% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -730,582 | -100.0% | -1.18% | – |
| ICLR | Exit | ICON PLC | $0 | – | -31,311 | -100.0% | -1.40% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -46,966 | -100.0% | -1.85% | – |
| PKI | Exit | PERKINELMER INC | $0 | – | -67,840 | -100.0% | -1.98% | – |
| DXCM | Exit | DEXCOM INC | $0 | – | -166,991 | -100.0% | -2.56% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -574,029 | -100.0% | -2.93% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -234,830 | -100.0% | -3.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.